Sirtex Medical Limited (ASX: SRX) has posted a strong lift in net profit to $40.35 million in its latest annual results.
The profit result was a 69 per cent increase on the previous year's $23.8 million figure.
The bio-medical company's revenue was also up by 35.6 per to $177.98 million.
Sirtex is currently working on a treatment for liver cancer and global dose sales of its SIR-Spheres increased by 19.8 per cent for the period.
The company will pay a fully-franked final dividend of 20 cents per share.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.025(2.30%) |
Mkt cap ! $20.89M | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.09 | $26.73K | 24.35K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6807 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 6617 | 1 |
View Market Depth
| Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
| OSL (ASX) Chart |